MarginsXMarginsX
Home › Markets › Health Care › DRIO

DarioHealth Corp. (DRIO)

DRIO trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.15
-8.73% on the day
Market cap
$13.0M
Nano cap
Revenue · 2025
$22.4M
-17.3% on 2024
Net income · 2025
-$41.7M
-186.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1533998/000110465926031621/0001104659-26-031621-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerDRIO on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryIsrael
IPO yearNot reported by the screener
SEC CIK0001533998
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$22.4M
Net income-$41.7M
Operating income-$36.7M
Net margin-186.6%
Operating margin-163.9%
Revenue growth-17.3%
Cash$21.8M
Total assets$110.1M
P/E (computed)Net income was not positive
P/S (computed)0.6×

Warning signs

Cash runway
14.2 months
$27.8M cash at September 30, 2026
Share count, 1 year
+66.8%
2025-11-11 to 2026-11-12 · +729.5% over 3 years
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$100K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$27.8M cash; operating cash flow -$5.9M a quarter.Report 2026-09-30
Shares outstanding11,287,022 (2026-11-12); 6,768,184 a year earlier; 27,214,670 three years earlier. 3y figure adjusted for split (1-for-20 overall).Cover page 2026-11-12
Reverse splits, 3 years1; latest 1-for-20 on 2025-08-28Source 2025-08-28
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-07-22
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKesselman & Kesselman C.P.A.s, Tel-Aviv, IsraelPCAOB Form AP 2026-04-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $100K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$5.3M-$8.8M-$5.5M$27.8M$31.2M$21.3M10-Q 2026-11-12
Q2 2026
2026-06-30
$5.2M-$7.9M-$6.1M$6.6M$31.1M$21.0M10-Q 2026-08-11
Q1 2026
2026-03-31
$5.6M-$8.2M-$6.0M$15.0M$30.9M$21.2M10-Q 2026-05-13
Q4 2025
2025-12-31
$5.2M-$9.0M-$5.9M$21.8M$30.7M$22.4M10-K 2026-03-19
Q3 2025
2025-09-30
$5.0M-$10.5M-$7.3M$31.9M$30.6M$24.7M10-Q 2026-11-12
Q2 2025
2025-06-30
$5.4M-$13.0M-$6.0M$22.0M$30.5M$27.1M10-Q 2026-08-11
Q1 2025
2025-03-31
$6.8M-$9.2M-$6.7M$27.9M$29.2M$28.0M10-Q 2026-05-13
Q4 2024
2024-12-31
$7.6M-$9.6M-$6.7M$27.8M$28.9M$27.0M10-K 2026-03-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-07-22
Latest annual report10-K2026-03-19
Latest quarterly / interim10-Q2026-11-12
Latest current report
FORM 8-K
8-K2026-11-06
Latest proxy
FORM DEF 14A
DEF 14A2025-12-22

Source: SEC EDGAR submissions feed, 906 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-46.9%
1 month-77.3%
3 months-82.8%
Year to date-88.9%
1 year-87.3%
From 52-week high-91.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
GUTSFractyl Health Inc.$0.9918+9.76%$13.2M
PAVMPAVmed Inc.$1.75+7.36%$14.0M
FEMYFemasys Inc.$1.28-8.57%$11.1M
CTSOCytosorbents Corporation$4.85-0.41%$15.3M
SNWVSANUWAVE Health Inc.$1.81-0.55%$15.6M
SINTSiNtx Technologies Inc.$1.34-1.11%$10.1M
RVPRetractable Technologies Inc.$0.5600+0.02%$16.8M
CVRXCVRx Inc.$0.6130+0.92%$17.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier